Wnt Pathway Activation in Long Term Remnant Rat Model
Elisenda Bañón-Maneus(Fundació Clínic per a la Recerca Biomèdica), Josep M. Campistol(Universitat de Barcelona)
Cited by 5
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k